cysteine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Coppo, P; Curie, A; De Meyer, SF; De Waele, L; Joly, BS; Kangro, K; Kaplanski, G; Männik, A; Roose, E; Tellier, E; Tersteeg, C; Vanhoorelbeke, K; Veyradier, A | 1 |
Ercig, B; Nicolaes, GAF; Reutelingsperger, CPM; Vanhoorelbeke, K; Voorberg, J; Wichapong, K | 1 |
Fujimura, Y; Ishizashi, H; Kokame, K; Maeda, H; Matsumoto, M; Miyata, T; Nakagaki, T; Nozaki, C; Soejima, K; Yagi, H | 1 |
Bouhassira, EE; Dong, L; Ginsburg, D; Tsai, HM; Zhou, W | 1 |
Bowen, DJ; Collins, PW | 1 |
2 review(s) available for cysteine and Congenital Thrombotic Thrombocytopenic Purpura
Article | Year |
---|---|
Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic Purpura.
Topics: ADAMTS13 Protein; Animals; Autoantibodies; Autoimmune Diseases; Computational Biology; Crystallography, X-Ray; Cysteine; Disease Models, Animal; Humans; Imaging, Three-Dimensional; Mutation; Peptides; Protein Conformation; Protein Domains; Purpura, Thrombotic Thrombocytopenic; Rituximab; Structure-Activity Relationship; Thrombospondins; von Willebrand Factor | 2018 |
Insights into von Willebrand factor proteolysis: clinical implications.
Topics: ABO Blood-Group System; ADAM Proteins; ADAMTS13 Protein; Amino Acids; Cysteine; Humans; Hydrolysis; Ligands; Models, Biological; Mutation; Polymorphism, Genetic; Purpura, Thrombotic Thrombocytopenic; Tyrosine; von Willebrand Diseases; von Willebrand Factor | 2006 |
3 other study(ies) available for cysteine and Congenital Thrombotic Thrombocytopenic Purpura
Article | Year |
---|---|
Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP.
Topics: ADAMTS13 Protein; Autoantibodies; Cysteine; Humans; Immunoglobulin G; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic | 2021 |
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.
Topics: ADAM Proteins; ADAMTS13 Protein; Autoantibodies; Cysteine; Epitope Mapping; Humans; Immunoglobulin G; Metalloendopeptidases; Mutagenesis, Site-Directed; Mutation; Protein Structure, Tertiary; Purpura, Thrombotic Thrombocytopenic; von Willebrand Factor | 2003 |
Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy?
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Autoantibodies; Blood Platelets; Chlorocebus aethiops; COS Cells; Cysteine; DNA Primers; Humans; Immunoglobulin G; Immunoprecipitation; Plasmids; Protein Binding; Protein Structure, Tertiary; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Temperature; Time Factors; von Willebrand Factor | 2005 |